Supplementary Table 2 from Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study

Xiao Ou Shu,Jirong Long,Wei Lu,Chun Li,Wendy Y. Chen,Ryan Delahanty,Jiarong Cheng,Hui Cai,Ying Zheng,Jiajun Shi,Kai Gu,Wen-Jing Wang,Peter Kraft,Yu-Tang Gao,Qiuyin Cai,Wei Zheng

DOI: https://doi.org/10.1158/0008-5472.22391478

2023-01-01

Abstract:PDF file - 42K

What problem does this paper attempt to address?

Supplementary Table 1 from Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study

Xiao Ou Shu,Jirong Long,Wei Lu,Chun Li,Wendy Y. Chen,Ryan Delahanty,Jiarong Cheng,Hui Cai,Ying Zheng,Jiajun Shi,Kai Gu,Wen-Jing Wang,Peter Kraft,Yu-Tang Gao,Qiuyin Cai,Wei Zheng

DOI: https://doi.org/10.1158/0008-5472.22391481

2023-01-01

Abstract:PDF file - 64K
Supplementary Table 1-3 from MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non–Small Cell Lung Cancer Patients

Xia Pu,Jack A. Roth,Michelle A.T. Hildebrandt,Yuanqing Ye,Hua Wei,John D. Minna,Scott M. Lippman,Xifeng Wu

DOI: https://doi.org/10.1158/0008-5472.22399995.v1

2023-01-01

Abstract:Supplementary Table 1-3 PDF file - 162K, Supplementary tables 1 and 2 include effect of selected SNPs on overall survival or recurrence in early stage NSCLC patients; Supplementary table 3 includes all the SNPs selected in the analysis
Supplementary Tables 1 - 3 from Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study

Xia Pu,Yuanqing Ye,Margaret R. Spitz,Liang Wang,Jian Gu,Scott M. Lippman,Michelle A.T. Hildebrandt,Waun Ki Hong,John D. Minna,Jack A. Roth,Ping Yang,Xifeng Wu

DOI: https://doi.org/10.1158/1078-0432.22446162

2023-01-01

Abstract:PDF file - 83k, Supplementary Table 1: Inflammation-related pathways selected in this study Supplementary Table 2: Effect of selected SNPs on survival in adenocarcinoma female patients Supplementary Table 3: Effect of selected SNPs on survival duration in patients with late-stage lung cancer Supplementary Table 4: Effect of selected SNPs on survival duration in patients by gender
Data from Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study

Xiao Ou Shu,Jirong Long,Wei Lu,Chun Li,Wendy Y. Chen,Ryan Delahanty,Jiarong Cheng,Hui Cai,Ying Zheng,Jiajun Shi,Kai Gu,Wen-Jing Wang,Peter Kraft,Yu-Tang Gao,Qiuyin Cai,Wei Zheng

DOI: https://doi.org/10.1158/0008-5472.c.6503271.v1

2023-01-01

Abstract:AbstractOnly two genome-wide association studies (GWAS) have been conducted to date to identify potential markers for total mortality after diagnosis of breast cancer. Here, we report the identification of two single-nucleotide polymorphisms (SNP) associated with total mortality from a two-stage GWAS conducted among 6,110 Shanghai-resident Chinese women with tumor–node–metastasis (TNM) stage I to IV breast cancer. The discovery stage included 1,950 patients and evaluated 613,031 common SNPs. The top 49 associations were evaluated in an independent replication stage of 4,160 Shanghai patients with breast cancer. A consistent and highly significant association with total mortality was documented for SNPs rs3784099 and rs9934948. SNP rs3784099, located in the RAD51L1 gene, was associated with total morality in both the discovery stage (P = 1.44 × 10−8) and replication stage (P = 0.06; P-combined = 1.17 × 10−7). Adjusted HRs for total mortality were 1.41 [95% confidence interval (CI), 1.18–1.68] for the AG genotype and 2.64 (95% CI, 1.74–4.03) for the AA genotype, when compared with the GG genotype. The variant C allele of rs9934948, located on chromosome 16, was associated with a similarly elevated risk of total mortality (P-combined = 5.75 × 10−6). We also observed this association among 1,145 patients with breast cancer of European ancestry from the Nurses’ Health Study (NHS; P = 0.006); the association was highly significant in a combined analysis of NHS and Chinese data (P = 1.39 × 10−7). Similar associations were observed for these two SNPs with breast cancer–specific mortality. This study provides strong evidence suggesting that the RAD51L1 gene and a chromosome 16 locus influence breast cancer prognosis. Cancer Res; 72(5); 1182–9. ©2012 AACR.
Supplementary Figure 1 from Genome-Wide Association Study of Genetic Predictors of Overall Survival for Non–Small Cell Lung Cancer in Never Smokers

Xifeng Wu,Liang Wang,Yuanqing Ye,Jeremiah A. Aakre,Xia Pu,Gee-Chen Chang,Pan-Chyr Yang,Jack A. Roth,Randolph S. Marks,Scott M. Lippman,Joe Y. Chang,Charles Lu,Claude Deschamps,Wu-Chou Su,Wen-Chang Wang,Ming-Shyan Huang,David W. Chang,Yan Li,V. Shane Pankratz,John D. Minna,Waun Ki Hong,Michelle A.T. Hildebrandt,Chao Agnes Hsiung,Ping Yang

DOI: https://doi.org/10.1158/0008-5472.22394888

2023-01-01

Abstract:PDF file - 587K, Manhattan Plot.
Supplementary Table 1 from Genetic Variation in VEGF Family Genes and Breast Cancer Risk: A Report from the Shanghai Breast Cancer Genetics Study

Alicia Beeghly-Fadiel,Xiao-Ou Shu,Wei Lu,Jirong Long,Qiuyin Cai,Yong-Bing Xiang,Ying Zheng,Zhongming Zhao,Kai Gu,Yu-Tang Gao,Wei Zheng

DOI: https://doi.org/10.1158/1055-9965.22435464.v1

2023-01-01

Abstract:Supplementary Table 1 from Genetic Variation in VEGF Family Genes and Breast Cancer Risk: A Report from the Shanghai Breast Cancer Genetics Study
Supplementary Table 1 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

Xiangchun Li,William K.K. Wu,Rui Xing,Sunny H. Wong,Yuexin Liu,Xiaodong Fang,Yanlin Zhang,Mengyao Wang,Jiaqian Wang,Lin Li,Yong Zhou,Senwei Tang,Shaoliang Peng,Kunlong Qiu,Longyun Chen,Kexin Chen,Huanming Yang,Wei Zhang,Matthew T.V. Chan,Youyong Lu,Joseph J.Y. Sung,Jun Yu

DOI: https://doi.org/10.1158/0008-5472.22410795.v1

2023-01-01

Abstract:Supplementary Table 1: Published publications and cohorts
Supplementary Table 6 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Genee Y. Lee,Peter M. Haverty,Li Li,Noelyn M. Kljavin,Richard Bourgon,James Lee,Howard Stern,Zora Modrusan,Somasekar Seshagiri,Zemin Zhang,David Davis,David Stokoe,Jeffrey Settleman,Frederic J. de Sauvage,Richard M. Neve

DOI: https://doi.org/10.1158/0008-5472.22399127

2023-01-01

Abstract:XLSX file - 29K, Analysis of expression (cancer versus normal) and association with outcome for PSMB4 and SHMT2.
Supplementary Table 7 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Genee Y. Lee,Peter M. Haverty,Li Li,Noelyn M. Kljavin,Richard Bourgon,James Lee,Howard Stern,Zora Modrusan,Somasekar Seshagiri,Zemin Zhang,David Davis,David Stokoe,Jeffrey Settleman,Frederic J. de Sauvage,Richard M. Neve

DOI: https://doi.org/10.1158/0008-5472.22399124

2023-01-01

Abstract:XLSX file - 37K, Supplementary materials and methods (cell lines, STR profiles, primers, antibodies, molecular reagents).
Supplementary Table 1 from Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations

Gordon Fehringer,Peter Kraft,Paul D. Pharoah,Rosalind A. Eeles,Nilanjan Chatterjee,Fredrick R. Schumacher,Joellen M. Schildkraut,Sara Lindström,Paul Brennan,Heike Bickeböller,Richard S. Houlston,Maria Teresa Landi,Neil Caporaso,Angela Risch,Ali Amin Al Olama,Sonja I. Berndt,Edward L. Giovannucci,Henrik Grönberg,Zsofia Kote-Jarai,Jing Ma,Kenneth Muir,Meir J. Stampfer,Victoria L. Stevens,Fredrik Wiklund,Walter C. Willett,Ellen L. Goode,Jennifer B. Permuth,Harvey A. Risch,Brett M. Reid,Stephane Bezieau,Hermann Brenner,Andrew T. Chan,Jenny Chang-Claude,Thomas J. Hudson,Jonathan K. Kocarnik,Polly A. Newcomb,Robert E. Schoen,Martha L. Slattery,Emily White,Muriel A. Adank,Habibul Ahsan,Kristiina Aittomäki,Laura Baglietto,Carl Blomquist,Federico Canzian,Kamila Czene,Isabel dos-Santos-Silva,A. Heather Eliassen,Jonine D. Figueroa,Dieter Flesch-Janys,Olivia Fletcher,Montserrat Garcia-Closas,Mia M. Gaudet,Nichola Johnson,Per Hall,Aditi Hazra,Rebecca Hein,Albert Hofman,John L. Hopper,Astrid Irwanto,Mattias Johansson,Rudolf Kaaks,Muhammad G. Kibriya,Peter Lichtner,Jianjun Liu,Eiliv Lund,Enes Makalic,Alfons Meindl,Bertram Müller-Myhsok,Taru A. Muranen,Heli Nevanlinna,Petra H. Peeters,Julian Peto,Ross L. Prentice,Nazneen Rahman,Maria Jose Sanchez,Daniel F. Schmidt,Rita K. Schmutzler,Melissa C. Southey,Rulla Tamimi,Ruth C. Travis,Clare Turnbull,Andre G. Uitterlinden,Zhaoming Wang,Alice S. Whittemore,Xiaohong R. Yang,Wei Zheng,Daniel D. Buchanan,Graham Casey,David V. Conti,Christopher K. Edlund,Steven Gallinger,Robert W. Haile,Mark Jenkins,Loïc Le Marchand,Li Li,Noralene M. Lindor,Stephanie L. Schmit,Stephen N. Thibodeau,Michael O. Woods,Thorunn Rafnar,Julius Gudmundsson,Simon N. Stacey,Kari Stefansson,Patrick Sulem,Y. Ann Chen,Jonathan P. Tyrer,David C. Christiani,Yongyue Wei,Hongbing Shen,Zhibin Hu,Xiao-Ou Shu,Kouya Shiraishi,Atsushi Takahashi,Yohan Bossé,Ma'en Obeidat,David Nickle,Wim Timens,Matthew L. Freedman,Qiyuan Li,Daniela Seminara,Stephen J. Chanock,Jian Gong,Ulrike Peters,Stephen B. Gruber,Christopher I. Amos,Thomas A. Sellers,Douglas F. Easton,David J. Hunter,Christopher A. Haiman,Brian E. Henderson,Rayjean J. Hung

DOI: https://doi.org/10.1158/0008-5472.22413282.v1

2023-01-01

Abstract:Variants selected for replication
Supplementary Data from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Jintao Guo,Ying Zhou,Chaoqun Xu,Qinwei Chen,Zsófia Sztupinszki,Judit Börcsök,Canqiang Xu,Feng Ye,Weiwei Tang,Jiapeng Kang,Lu Yang,Jiaxin Zhong,Taoling Zhong,Tianhui Hu,Rongshan Yu,Zoltan Szallasi,Xianming Deng,Qiyuan Li

DOI: https://doi.org/10.1158/0008-5472.22361539.v1

2023-01-01

Abstract:Supplementary Methods, Figures S1-S8, Table S1-S4
Table S8 from Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients

Jun Sun,Hua Meng,Yao Lu,Meng Lv,Jing Bai,Jianguang Zhang,Lientu Wang,Tao Ouyang,Jinfeng Li,Tianfeng Wang,Zhaoqing Fan,Tie Fan,Benyao Lin,Y. G. Xie

DOI: https://doi.org/10.1158/1078-0432.22463211.v1

2023-01-01

Abstract:Survival in Molecular Subgroups
Table S6 from Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients

Jie Sun,Hua Meng,Lu Yao,Meng Lv,Jian Bai,Jianguang Zhang,Lientu Wang,Tao Ouyang,Jinfeng Li,Tianfeng Wang,Zhaoqing Fan,Tie Fan,Benyao Lin,Yuntao Xie

DOI: https://doi.org/10.1158/1078-0432.22463217.v1

2023-01-01

Abstract:Univariate Analyses of Disease-free Survival and Disease-specific Survival
Supplementary Figure A1 from Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer

Ke‐Da Yu,Rui Zhu,Mei Zhan,Angel Rodriguez,Wei Yang,Stephen T.C. Wong,Andreas Makris,Brian D. Lehmann,Xi Chen,Ingrid A. Mayer,Jennifer A. Pietenpol,Zhi‐Ming Shao,W. Fraser Symmans,Jenny Chang‐Claude

DOI: https://doi.org/10.1158/1078-0432.22446909

2023-01-01

Abstract:Supplementary Figure A1 PDF file 73K, Subgroup analysis of the extended validation cohort
Supplementary Tables 1-2, Figures 1-2 from Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma

Yong Guo,Zhaoli Chen,Liang Zhang,Fang Zhou,Susheng Shi,Xiaoli Feng,Baozhong Li,Xin Meng,Xi Ma,Mingyong Luo,Kang Shao,Ning Li,Bin Qiu,Keith Mitchelson,Jing Cheng,Jie He

DOI: https://doi.org/10.1158/0008-5472.22371494

2023-01-01

Abstract:Supplementary Tables 1-2, Figures 1-2 from Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma
Table S2-S3 from A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer

Bo Zhang,Men-Yun Chen,Yu-Jun Shen,Xian-Bo Zhuo,Ping Gao,Fu-Sheng Zhou,Bo Liang,Jun Zu,Qin Zhang,Sufyan Suleman,Yi-Hui Xu,Min-Gui Xu,Jin-Kai Xu,Chen-Cheng Liu,Nikolaos Giannareas,Ji-Han Xia,Yuan Zhao,Zhong-Lian Huang,Zhen Yang,Huai-Dong Cheng,Na Li,Yan-Yan Hong,Wei Li,Min-Jun Zhang,Ke-Da Yu,Guoliang Li,Meng-Hong Sun,Zhen-Dong Chen,Gong-Hong Wei,Zhi-Min Shao

DOI: https://doi.org/10.1158/0008-5472.22417575

2023-01-01

Abstract:Table S2-S3 inlcude siRNAs and primers used in this study.
Supplementary Table 2 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Genee Y. Lee,Peter M. Haverty,Li Li,Noelyn M. Kljavin,Richard Bourgon,James Lee,Howard Stern,Zora Modrusan,Somasekar Seshagiri,Zemin Zhang,David Davis,David Stokoe,Jeffrey Settleman,Frederic J. de Sauvage,Richard M. Neve

DOI: https://doi.org/10.1158/0008-5472.22399139

2023-01-01

Abstract:XLSX file - 112K, GISTIC analysis of tumour samples.
Supporting Table 3 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Yunping Qiu,Guoxiang Cai,Bingsen Zhou,Dan Li,Aihua Zhao,Gary Xie,Houkai Li,Sanjun Cai,Dong Xie,Changzhi Huang,Weiting Ge,Zhanxiang Zhou,Lisa X. Xu,Jia Wang,Shusen Zheng,Yun Yen

DOI: https://doi.org/10.1158/1078-0432.22449215

2023-01-01

Abstract:PDF file 50K, Treatment information for stage II and stage III patients in Shanghai cohort
Table S1 from A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer

Bo Zhang,Men-Yun Chen,Yu-Jun Shen,Xian-Bo Zhuo,Ping Gao,Fu-Sheng Zhou,Bo Liang,Jun Zu,Qin Zhang,Sufyan Suleman,Yi-Hui Xu,Min-Gui Xu,Jin-Kai Xu,Chen-Cheng Liu,Nikolaos Giannareas,Ji-Han Xia,Yuan Zhao,Zhong-Lian Huang,Zhen Yang,Huai-Dong Cheng,Na Li,Yan-Yan Hong,Wei Li,Min-Jun Zhang,Ke-Da Yu,Guoliang Li,Meng-Hong Sun,Zhen-Dong Chen,Gong-Hong Wei,Zhi-Min Shao

DOI: https://doi.org/10.1158/0008-5472.22417578.v1

2023-01-01

Abstract:Associations of selected SNPs in the screening and the replication stages.
Supplementary Table 2 from An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer

Mark L. McCleland,Adam S. Adler,Yonglei Shang,Thomas Hunsaker,Tom Truong,David Peterson,Eric Torres,Li Li,Benjamin Haley,Jean-Philippe Stephan,Marcia Belvin,Georgia Hatzivassiliou,Elizabeth M. Blackwood,Laura Corson,Marie Evangelista,Jiping Zha,Ron Firestein

DOI: https://doi.org/10.1158/0008-5472.22394592

2023-01-01

Abstract:XLSX file - 59K, Genes that comprise the glycolysis and oxidative phosphorylation gene signatures

Supplementary Table 2 from Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study

Supplementary Table 1 from Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study

Supplementary Table 1-3 from MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non–Small Cell Lung Cancer Patients

Supplementary Tables 1 - 3 from Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study

Data from Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study

Supplementary Figure 1 from Genome-Wide Association Study of Genetic Predictors of Overall Survival for Non–Small Cell Lung Cancer in Never Smokers

Supplementary Table 1 from Genetic Variation in VEGF Family Genes and Breast Cancer Risk: A Report from the Shanghai Breast Cancer Genetics Study

Supplementary Table 1 from Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability

Supplementary Table 6 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Table 7 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Table 1 from Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations

Supplementary Data from Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers

Table S8 from Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients

Table S6 from Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients

Supplementary Figure A1 from Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer

Supplementary Tables 1-2, Figures 1-2 from Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma

Table S2-S3 from A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer

Supplementary Table 2 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supporting Table 3 from A Distinct Metabolic Signature of Human Colorectal Cancer with Prognostic Potential

Table S1 from A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer

Supplementary Table 2 from An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer